首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1575722

全球無針抽血設備市場 - 2024-2031

Global Needle Free Blood Drawing Devices Market - 2024-2031

出版日期: 2024年10月22日 | 出版商:

DataM Intelligence | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

2023年，全球無針抽血設備市場規模達到144.3億美元，預計2031年將達到265.2億美元，2024-2031年預測期間複合年成長率為7.9%。

無針抽血裝置為依賴針頭和注射器的傳統採血方法提供了無痛替代方案。這些設備將微粒發射到皮膚中，形成一個微小的開口，可以利用負壓提取血液。這項創新技術大大減少了患者的不適，並降低了針刺傷的可能性，這是傳統採血方法中常見的問題。

無針裝置的主要好處在於它們能夠減輕抽血相關的疼痛，解決了許多患者的重大問題。這些設備顯著降低了醫療保健專業人員被針刺傷的可能性，從而降低了傳播血源性病原體的風險。

許多無針設備設計得直覺、簡單，適合在家庭環境中使用，這可以提高患者對定期健康監測的依從性。這些設備經常利用尖端技術，例如微粒推進或毛細管作用，無需傳統針頭即可進行血液收集。

市場動態：

司機

無痛替代品的需求不斷增加

全球無針採血設備市場的需求受到多種因素的推動。主要因素之一是對無痛替代品的需求不斷增加。在美國，人們對無針抽血設備的日益青睞主要是由於對減少痛苦的醫療程序的渴望，特別是對傳統針刺方法感到焦慮或不適的患者。這種趨勢在進行大量抽血的醫院中非常重要，影響臨床決策和病患照護。

傳統的採血技術，如靜脈穿刺，經常給患者帶來相當大的疼痛和焦慮。這種不適源於將針插入皮膚和靜脈的過程，這對於害怕針的人或需要定期抽血的人來說尤其麻煩。

此外，該行業的主要參與者更加關注有助於推動該市場成長的技術進步。例如，2022 年 4 月，Winnoz Technology 開發的 Haiim 裝置透過提供傳統靜脈穿刺的無針替代方案，代表了血液採集方法的重大進步。這款創新設備旨在從指尖採集血液樣本，利用真空輔助技術快速、輕鬆地抽取 150 至 500 微升全血。

此外，2022 年 2 月，Tasso, Inc. 推出了 Tasso Care for Prescreening，這是一項綜合服務解決方案，旨在增強臨床試驗的預篩選流程。該服務旨在利用 Tasso 創新的遠端採血技術來簡化參與者的招募，該技術以患者為中心並經過臨床驗證。

限制

設備成本高、設備可用性有限、報銷政策有限等因素預計將阻礙市場發展。

細分市場分析

全球無針採血設備市場根據產品類型、技術、最終用戶和地區進行細分。

醫院細分市場約佔全球無針採血設備市場佔有率的65.6%

預計醫院部門將在預測期內佔據最大的市場佔有率。美國每年抽血頻率不斷增加，刺激了對無針替代品的需求。在醫院裡，許多患者可能每天需要多次抽血，而由於肥胖、年齡或潛在健康狀況而導致靜脈通路困難等挑戰增加了無針解決方案的必要性。醫院在醫療保健產業中發揮著至關重要的作用，影響多達 70% 的臨床決策，凸顯了有效的採血方法的重要性。

此外，主要參與者的產品發布和批准以及創新技術的發展正在推動該細分市場在該市場的成長。例如，2023 年 11 月，BD (Becton, Dickinson and Company) 在獲得美國食品藥物管理局 (FDA) 的 510(k) 許可後推出了 PIVO Pro 無針採血設備。這款新設備旨在與整合式導管配合使用，旨在推進 BD 的「單根住院」願景。

同樣，YourBio Health 開發了 HALO 技術，該技術透過使用專利的無刀片微針陣列顯著改善血液採集過程，從而實現幾乎無痛的抽血。此外，2024年4月，YourBio Health開發的第一代TAP（觸摸激活靜脈放血）設備代表了採血技術的重大突破。它提供了一種易於使用、幾乎無痛的傳統抽血替代方案，使其適合臨床和遠端臨床環境。

市場地理分析

北美約佔全球無針採血設備市場佔有率的46.2%

由於對無痛替代品的需求不斷增加以及大量抽血將推動美國市場的成長，預計北美地區將在預測期內佔據最大的市場佔有率

此外，FDA等監管機構的批准對於無針採血設備在美國的推廣和使用至關重要。能夠獲得這些批准的公司（例如擁有 PIVO 設備的 BD）將能夠在市場上獲得競爭優勢。在該地區，大量關鍵參與者的存在、技術進步、先進的醫療基礎設施、產品發布和批准以及意識計劃、夥伴關係和協作等政府舉措正在推動該市場的成長。

例如，2023 年 12 月，BD (Becton, Dickinson and Company) 的新型 BD MiniDraw 毛細血管採血系統獲得了美國食品藥物管理局 (FDA) 的 510(k) 許可。這種創新的指尖採血裝置旨在透過指尖採血採集血液樣本，為傳統靜脈抽血提供一種侵入性較小的替代方案。該系統允許訓練有素的醫療保健專業人員從較小體積的血液中獲得實驗室質量的結果，使其適用於各種常見的測試。

此外，2022 年 10 月，Catapult Health 和 Tasso 合作，將 Tasso+ 自採樣血液採集設備整合到美國大公司和國家健康計畫員工的年度醫療保健檢查中。此次合作旨在提高常規健康評估期間血液檢測的效率和舒適度。

Needle-free blood drawing devices offer a painless alternative to conventional blood collection methods that rely on needles and syringes. These devices launch a micro-particle into the skin, creating a tiny opening that allows blood to be extracted using negative pressure. This innovative technique greatly diminishes patient discomfort and lowers the likelihood of needle-stick injuries, a common issue associated with traditional blood collection methods.

The primary benefit of needle-free devices lies in their capacity to alleviate the pain associated with blood draws, addressing a significant concern for numerous patients. These devices significantly diminish the likelihood of needle-stick injuries among healthcare professionals, thereby reducing the risk of transmitting blood-borne pathogens.

Many needle-free devices are crafted to be intuitive and straightforward, making them suitable for use in home environments, which can improve patient adherence to regular health monitoring. These devices frequently utilize cutting-edge technologies, such as micro-particle propulsion or capillary action, to enable blood collection without the need for traditional needles.

Market Dynamics: Drivers

Increasing demand for pain-free alternatives

The demand for the global needle-free blood drawing devices market is driven by multiple factors. One of the primary factors is the increasing demand for pain-free alternatives. The growing preference for needle-free blood drawing devices in the U.S. is largely driven by the desire for less painful medical procedures, particularly among patients who experience anxiety or discomfort with traditional needle-based methods. This trend is significant in hospitals where a high volume of blood draws occurs, impacting clinical decisions and patient care.

Conventional blood collection techniques, like venipuncture, frequently cause considerable pain and anxiety for patients. This discomfort stems from the process of inserting needles into the skin and veins, which can be especially troubling for individuals who have a fear of needles or for those who need to undergo blood draws regularly.

Moreover, key players in the industry more focus on technological advancements that help to propel this market growth. For instance, in April 2022, the Haiim device, developed by Winnoz Technology, represents a significant advancement in blood collection methods by offering a needle-free alternative to traditional venipuncture. This innovative device is designed to collect blood samples from the fingertips, utilizing vacuum-assisted technology to draw between 150 and 500 microliters of whole blood quickly and less painfully.

Also, in February 2022, Tasso, Inc. launched Tasso Care for Prescreening, a comprehensive service solution designed to enhance the prescreening process for clinical trials. This service aims to streamline the recruitment of participants by utilizing Tasso's innovative remote blood collection technology, which is patient-centric and clinically validated.

Restraints

Factors such as the high cost of devices, limited availability of devices, and limited reimbursement policies are expected to hamper the market.

Market Segment Analysis

The global needle-free blood drawing devices market is segmented based on product type, technology, end-user, and region.

The hospital's segment accounted for approximately 65.6% of the global needle-free blood drawing devices market share

The hospital segment is expected to hold the largest market share over the forecast period. The rising frequency of blood draws conducted each year in the U.S. is fueling the demand for needle-free alternatives. In hospitals, numerous patients may require several blood draws each day, and challenges such as difficult venous access often due to obesity, age, or underlying health conditions are increasing the necessity for needle-free solutions. Hospitals play a vital role in the healthcare industry, affecting as much as 70% of clinical decisions, which underscores the importance of effective blood collection methods.

Moreover, key player's product launches & approvals and innovative technological developments are driving this segment's growth in this market. For instance, in November 2023, BD (Becton, Dickinson and Company) launched the PIVO Pro Needle-free Blood Collection Device after receiving 510(k) clearance from the U.S. Food and Drug Administration (FDA). This new device is designed to work with integrated catheters and aims to advance BD's vision of a "One-Stick Hospital Stay."

Similarly, YourBio Health developed the HALO Technology, created by significantly improving the blood collection process by using a patented bladeless microneedle array, which facilitates nearly painless blood draws. Also, in April 2024, the 1st generation TAP (Touch Activated Phlebotomy) device developed by YourBio Health represented a significant breakthrough in blood collection technology. It offered an easy-to-use, virtually painless alternative to traditional blood draws, making it suitable for clinical and remote clinical settings.

Market Geographical Analysis

North America accounted for approximately 46.2% of the global needle-free blood drawing devices market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing demand for pain-free alternatives and a high volume of blood draws that would propel this market growth in the U.S.

Moreover, Approval from regulatory agencies such as the FDA is crucial for the promotion and utilization of needle-free blood drawing devices in the United States. Companies that can secure these approvals, like BD with its PIVO device, are positioned to gain a competitive advantage in the marketplace. In this region, a major number of key players' presence, technological advancements, well-advanced healthcare infrastructure, product launches & approvals, and government initiatives such as awareness programs, partnerships & collaborations are driving this market growth.

For instance, in December 2023, BD (Becton, Dickinson and Company) received 510(k) clearances from the U.S. Food and Drug Administration (FDA) for its new BD MiniDraw Capillary Blood Collection System. This innovative fingertip blood collection device is designed to collect blood samples through a fingerstick, providing a less invasive alternative to traditional venous blood draws. The system allows trained healthcare professionals to obtain lab-quality results from a smaller volume of blood, making it suitable for various common tests.

Also, in October 2022, Catapult Health and Tasso partnered to integrate the Tasso+ self-sampling blood collection device into annual healthcare checkups for employees at major corporations and national health plans in the USA. This collaboration aims to enhance the efficiency and comfort of blood testing during routine health assessments.

Market Segmentation

By Product Type

Handheld Devices

Wearable Devices

By Technology

Venipuncture

Touch-Based

By End-Users

Hospitals

Ambulatory Surgical Centers

Diagnostic Laboratories

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the needle-free blood drawing devices market include Becton, Dickinson and Company (BD), YourBio Health, Inc., Tasso, Inc., Romsons, AlphaBiolabs Ltd, Loop Medical SA., Utah Medical Products, Inc., ICU Medical, Inc., and Winnoz Technology, Inc.

Key Developments

In November 2023, BD introduced the PIVO Pro Needle-free Blood Collection Device, which allows blood samples to be drawn directly from a patient's peripheral IV line without using a traditional needle. This innovative device builds upon BD's existing PIVO technology that was first introduced for use with short peripheral IV catheters. The PIVO Pro is designed to be compatible with integrated catheters, including the new Nexiva Closed IV Catheter System with NearPort V Access

In March 2022, Vitestro launched an autonomous blood collection device designed to empower patients by allowing them to participate actively in their blood draw procedures. This innovative venipuncture device utilizes advanced technology, including artificial intelligence and ultrasound-guided imaging, combined with robotic needle insertion, to automate the blood collection process.

Why Purchase the Report?

To visualize the global needle-free blood drawing devices market segmentation based on product type, technology, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the needle-free blood drawing devices market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global needle-free blood drawing devices market report would provide approximately 59 tables, 50 figures, and 184 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product type
3.2. Snippet by Technology
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Demand for Pain-Free Alternatives
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Devices
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Handheld Devices *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Wearable Devices

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Venipuncture *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Touch-Based

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers
8.4. Diagnostic Laboratories
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Becton, Dickinson and Company (BD) *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. YourBio Health, Inc.
11.3. Tasso, Inc.
11.4. Romsons
11.5. AlphaBiolabs Ltd
11.6. Loop Medical SA.
11.7. Utah Medical Products, Inc.
11.8. ICU Medical, Inc.
11.9. Winnoz Technology, Inc. (*LIST NOT EXHAUSTIVE)